The aim of stem cell therapy after cardiac injury is to replace damaged cardiac tissue. Human cardiac progenitor cells (CPCs) represent an interesting cell population for clinical strategies to treat cardiac disease and human CPC-specific antibodies would aid in the clinical implementation of cardiac progenitor-based cell therapy. However, the field of CPC biology suffers from the lack of human CPC-specific markers. Therefore, we raised a panel of monoclonal antibodies (mAb) against CPCs. Of this panel of antibodies, we show that mAb C1096 recognizes a progenitor-like population in the fetal and adult human heart and partially colocalize with reported CPC populations in vitro. Furthermore, mAb C1096 can be used to isolate a multipotent progenitor population from human heart tissue. Interestingly, the two lead candidates, mAb C1096 and mAb C19, recognize glycosylated residues on PECAM1 (platelet and endothelial cell adhesion molecule 1) and GRP78, respectively, and de-N-glycosylation significantly abolishes their binding. Thereby, this report describes new clinically applicable antibodies against human CPCs, and for the first time demonstrates the importance of glycosylated residues as CPCs specific markers.
Get full access to this article
View all access options for this article.
References
1.
MoerkampAT and GoumansM-J. (2012). Cardiac regeneration: stem cells and beyond. Curr Med Chem, 19:5993–6002.
2.
ValenteM, NascimentoDS, CumanoA and Pinto-do-ÓP. (2014). Sca-1+ cardiac progenitor cells and heart-making: a critical synopsis. Stem Cells Dev, 23:2263–2273.
3.
LeiteCF, AlmeidaTR, LopesCS and Dias da SilvaVJ. (2015). Multipotent stem cells of the heart-do they have therapeutic promise?. Front Physiol, 6:123.
4.
GoumansMJ, de BoerTP, SmitsAM, van LaakeLW, van VlietP, MetzCHG, KorfageTH, KatsKP, HochstenbachR, et al. (2008). TGF-β1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res, 1:138–149.
5.
SmitsAM, van VlietP, MetzCH, KorfageT, SluijterJP, DoevendansPA and GoumansM-J. (2009). Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat Protoc, 4:232–243.
6.
SmitsAM, Van LaakeLW, Den OudenK, SchreursC, SzuhaiK, Van EchteldCJ, MummeryCL, DoevendansPA and GoumansMJ. (2009). Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res, 83:527–535.
7.
VrijsenKR, SluijterJPG, SchuchardtMWL, van BalkomBWM, NoortWA, ChamuleauSAJ and DoevendansPAFM. (2010). Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J Cell Mol Med, 14:1064–1070.
8.
VrijsenKR, MaringJA, ChamuleauSAJ, VerhageV, MolEA, DeddensJC, MetzCHG, LodderK, van EeuwijkECM, et al. (2016). Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis via EMMPRIN. Adv Healthc Mater, 5:2555–2565.
9.
HolmesC and StanfordWL. (2007). Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells, 25:1339–1347.
10.
LeungHW, MoerkampAT, PadmanabhanJ, NgS-W, GoumansM-J and ChooA. (2015). mAb C19 targets a novel surface marker for the isolation of human cardiac progenitor cells from human heart tissue and differentiated hESCs. J Mol Cell Cardiol, 82:228–237.
11.
BergerRP, DookwahM, SteetR and StephenD. (2016). Glycosylation and stem cells: regulatory roles and application of iPSCs in the study of glycosylation-related disorders. Bioessays, 38:1255–1265.
12.
HaltiwangerRS and LoweJB. (2004). Role of glycosylation in development. Annu Rev Biochem, 73:491–537.
13.
WangY-C, PetersonSE and LoringJF. (2014). Protein post-translational modifications and regulation of pluripotency in human stem cells. Cell Res, 24:143–160.
14.
Pérez-PomaresJM, MironovV, GuadixJA, MacíasD, MarkwaldRR and Muñoz-ChápuliR. (2006). In vitro self-assembly of proepicardial cell aggregates: an embryonic vasculogenic model for vascular tissue engineering. Anat Rec A Discov Mol Cell Evol Biol, 288:700–713.
15.
AndersS and HuberW. (2012). Differential Expression of RNA-Seq Data at the Gene Level—The DESeq Package. EMBL, Heidelberg, Ger, 11:R106.
16.
van VlietP, RoccioM, SmitsAM, van OorschotAA, MetzCH, van VeenTA, SluijterJP, DoevendansPA and GoumansMJ. (2008). Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Neth Hear J, 16:163–169.
17.
SmitsA and RileyP. (2014). Epicardium-derived heart repair. J Dev Biol, 2:84–100.
18.
MessinaE, De AngelisL, FratiG, MorroneS, ChimentiS, FiordalisoF, SalioM, BattagliaM, LatronicoMVG, et al. (2004). Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res, 95:911–921.
19.
Den HartoghSC, SchreursC, Monshouwer-KlootsJJ, DavisRP, ElliottDA, MummeryCL and PassierR. (2015). Dual reporter MESP1 mCherry/w-NKX2-5 eGFP/w hESCs enable studying early human cardiac differentiation. Stem Cells, 33:56–67.
20.
AlbeldaSM, OliverPD, RomerLH and BuckCA. (1990). EndoCAM: a novel endothelial cell-cell adhesion molecule. J Cell Biol, 110:1227–1237.
21.
WattSM, WilliamsonJ, GenevierH, FawcettJ, SimmonsDL, HatzfeldA, NesbittSA and CoombeDR. (1993). The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. Blood, 82:2649–2663.
22.
BaumannCI, BaileyAS, LiW, FerkowiczMJ, YoderMC and FlemingWH. (2004). PECAM-1 is expressed on hematopoietic stem cells throughout ontogeny and identifies a population of erythroid progenitors. Blood, 104:1010–1016.
23.
BolliniS, VieiraJMN, HowardS, DubèKN, BalmerGM, SmartN and RileyPR. (2014). Re-activated adult epicardial progenitor cells are a heterogeneous population molecularly distinct from their embryonic counterparts. Stem Cells Dev, 23:1719–1730.
24.
PesceM, BurbaI, GambiniE, PrandiF, PompilioG and CapogrossiMC. (2011). Endothelial and cardiac progenitors: boosting, conditioning and (re)programming for cardiovascular repair. Pharmacol Ther, 129:50–61.
25.
BearziC, LeriA, Lo MonacoF, RotaM and AnversaP. (2009). Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A, 106:15885–15890.
26.
BearziC, RotaM, HosodaT, TillmannsJ, NascimbeneA, De AngelisA, Yasuzawa-AmanoS, TrofimovaI, SigginsRW, LecapitaineN, et al. (2007). Human cardiac stem cells. Proc Natl Acad Sci U S A, 104:14068–14073.
27.
HierlihyAM, SealeP, LobeCG, RudnickiMA and MegeneyLA. (2002). The post-natal heart contains a myocardial stem cell population. FEBS Lett, 530:239–243.
28.
PfisterO, MouquetF, JainM, SummerR, HelmesM, FineA, ColucciWS and LiaoR. (2005). CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res, 97:52–61.
29.
MeilhacSM, EsnerM, KellyRG, NicolasJF and BuckinghamME. (2004). The clonal origin of myocardial cells in different regions of the embryonic mouse heart. Dev Cell, 6:685–698.
30.
NashR, NevesL, FaastR, PierceM and DaltonS. (2007). The lectin Dolichos biflorus agglutinin recognizes glycan epitopes on the surface of murine embryonic stem cells: a new tool for characterizing pluripotent cells and early differentiation. Stem Cells, 25:974–982.
31.
Alisson-SilvaF, De Carvalho RodriguesD, VairoL, AsensiKD, Vasconcelos-Dos-SantosA, MantuanoNR, DiasWB, RondinelliE, RGoldenbergCDS, UrmenyiTP and TodeschiniAR. (2014). Evidences for the involvement of cell surface glycans in stem cell pluripotency and differentiation. Glycobiology, 24:458–468.
32.
WangY-C, SteinJW, LynchCL, TranHT, LeeC-Y, ColemanR, HatchA, AntontsevVG, ChyHS, et al. (2015). Glycosyltransferase ST6GAL1 contributes to the regulation of pluripotency in human pluripotent stem cells. Sci Rep, 5:13317.
33.
KawamuraT, MiyagawaS, FukushimaS, KashiyamaN, KawamuraA, ItoE, SaitoA, MaedaA, EguchiH, et al. (2015). Structural changes in N-glycans on induced pluripotent stem cells differentiating toward cardiomyocytes. Stem Cells Transl Med, 4:1258–1264.
34.
BergerRP, SunYH, KulikM, LeeJK, NairnAV, MoremenKW, PierceM and DaltonS. (2016). ST8SIA4 dependent polysialylation is part of a developmental program required for germ layer formation from human pluripotent stem cells. Stem Cells, 34:1742–1752.
35.
MedfordHM and MarshSA. (2014). The role of O-GlcNAc transferase in regulating the gene transcription of developing and failing hearts. Future Cardiol, 10:801–812.
36.
WatsonLJ, LongBW, DeMartinoAM, BrittianKR, ReadnowerRD, BrainardRE, CumminsTD, AnnamalaiL, HillBG and JonesSP. (2014). Cardiomyocyte Ogt is essential for postnatal viability. Am J Physiol Heart Circ Physiol, 306:142–153.
37.
WatsonLJ, FacundoHT, NgohGA, AmeenM, BrainardRE, LemmaKM, LongBW, PrabhuSD, XuanY-T and JonesSP. (2010). O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart. Proc Natl Acad Sci U S A, 107:17797–17802.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
